/
ABSCF
$1.12+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$1.12 – $1.45
0% from low
Exchange
OTC Link
OS
Price (6 mo)
Loading chart…
Change$-12.63
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.7M | $1.6M | $1.6M | $1.6M | $958.0K | $970.0K | $1.1M | $1.2M |
| Cost of revenue | $248.0K | $181.0K | $69.0K | $111.0K | $31.0K | $383.0K | −$176.0K | $453.8K |
| Gross profit | $1.5M | $1.4M | $1.5M | $1.5M | $927.0K | $587.0K | $1.2M | $719.7K |
| Gross margin | 85.4% | 88.5% | 95.6% | 93.1% | 96.8% | 60.5% | 116.4% | 61.3% |
| R&D | $26.9M | $15.6M | $12.8M | $11.2M | $13.3M | $13.9M | $3.9M | −$233.9K |
| Operating income | −$28.9M | −$17.5M | −$14.7M | −$13.8M | −$15.9M | −$13.4M | −$6.1M | −$1.2M |
| EBITDA | −$25.1M | −$20.9M | −$13.8M | −$12.7M | −$15.5M | −$12.8M | −$4.9M | −$958.6K |
| Net income | −$26.1M | −$21.7M | −$15.0M | −$14.5M | −$13.6M | −$12.0M | −$7.8M | −$1.6M |
| Net margin | -1532.1% | -1384.3% | -950.4% | -900.0% | -1421.2% | -1235.6% | -730.5% | -132.6% |
| EPS (diluted) | -0.79 | -0.62 | -0.34 | -0.30 | -0.29 | -0.24 | -0.15 | -0.03 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1M | $-0.15 | $-0.15–$-0.15 | 1 |
| 2027 | $1M | $-0.14 | $-0.14–$-0.14 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
AB SCIENCE PARIS ORD
AB SCIENCE PARIS ORD
Held by traders on TradeandTell
No one on the platform currently holds ABSCF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ABSCF as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded ABSCF yet.